about
Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamilyMal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transductionInterleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signalingCloning of a putative ligand for the T1/ST2 receptorThe chromosomal location of T-cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemiaInterleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activityOpposing activities of two novel members of the IL-1 ligand family regulate skin inflammationExpression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domainsA new nomenclature for IL-1-family genesInterleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKsIL-36R ligands are potent regulators of dendritic and T cellsIdentification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signalingMolecular cloning and biological characterization of a novel murine lymphoid growth factorExternalization of the leaderless cytokine IL-1F6 occurs in response to lipopolysaccharide/ATP activation of transduced bone marrow macrophagesAnnotating genes with potential roles in the immune system: six new members of the IL-1 familyT-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14.Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.IL-1 and IL-18 receptors, and their extended family.Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory protein.The IL-1 family: regulators of immunity.Molecular characterisation of cytokine receptors.IL-36 in psoriasis.The interleukin-1 receptor.Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.Interleukin-1 receptors.The two interleukin-1 receptors play different roles in IL-1 actions.Phorbol ester induces phosphorylation of the 80 kilodalton murine interleukin 1 receptor at a single threonine residue.Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.Retention of ligand binding activity by the extracellular domain of the IL-1 receptor.Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes.A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.Novel protein therapeutic joint retention strategy based on collagen-binding Avimers.Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis.CD121a.
P50
Q22009907-98269497-120D-4D04-B210-0D5A0897A117Q24291653-E9FCF131-5154-44AD-87C3-7D19B2811AD3Q24310038-D663F26E-F66F-453D-A337-D97D0D92DBAFQ24316441-BD478710-E086-48A2-A88B-853103193532Q24336693-EEC3F9B9-E160-449A-A498-4F4D4984BE4EQ24555805-BBDE2F77-2F74-47DA-8F69-47EEE3279487Q24630062-5CF32909-E72D-40C9-8130-5C4CF5A5B0FAQ24676343-B55BBF5B-5437-4905-A48D-EB5C220C81C1Q24682612-AA1D6A62-FEF6-4309-A3D1-0B94A535909EQ28189011-152B9D97-33B5-45D1-8683-D278E63D2469Q28239808-FCA6D911-AFA1-4910-BA55-FE0EBCD5A340Q28508623-FE9CE14D-B3B9-48B5-B164-7E96B7804E5AQ28592094-52AE48C4-5B5F-4968-BE91-5D05C7A2B8DFQ28593030-D167B97B-4CEC-44C9-A764-CC7C1AD57422Q28593971-FADE8C8E-D3DA-4DAC-B5DA-4D5994373AF2Q28679180-6FAF290E-C7B3-4FFB-8668-7DB6D227DD51Q33852086-9155AC59-A653-4299-B1BD-7FC8E1B85C19Q34325931-AFBB4517-8FD4-45C0-865D-0F9589C23000Q34327545-7F45D8B3-F1C8-4AD4-BF2A-E657D8FE5E24Q34395240-53E1CEB5-3492-4614-8002-28C9ED2D8E92Q34400469-8FF7E6C7-F038-4BAA-A206-2F151BD4C6CBQ34479550-F45A20DC-B154-488C-A13C-B8DE61718D6DQ34493066-4CD38342-42BF-442F-9A7B-57707B17304BQ35680208-2AAACC4C-C84D-4B2F-B29B-1388EC256F03Q37676929-C3886DAD-FEC0-497E-BE7D-A6A098C36840Q37856276-C78C9208-5138-45F8-8A87-811C0292EE02Q37991473-0860A166-F33A-438A-ACD9-96E371029EEDQ38263212-F1EDDDCE-3C19-4189-8CD0-5B48CF6B5386Q39217108-82FA9597-78A2-4C62-9C1E-BB5EF817F2E1Q40512148-285D6201-5109-426E-96A8-96284EDD28C1Q40666059-4959C4B7-CD0A-4BEA-915A-6BE7E10521A7Q41683458-1E0F5259-3A32-468F-AC29-BDDFDDC9A538Q41838290-E38EDC6A-BDE2-4A39-A9E3-29BD574AEFBDQ42057328-21FDEB08-ED2B-41E5-98D3-D05275C74983Q42455196-00237809-BAF7-4FBE-AC77-9F63DC42ACCCQ43587591-3AC74C56-6FB9-452F-AF5D-C53FEC8155F3Q43978795-96C4B724-EB94-41EA-830A-73B2D373E581Q46110988-0DCAAE04-EDE0-494E-AF12-E1047436C3AFQ47363332-DDB72F90-25A6-45BA-8794-8CA74625C5F7Q47855634-9F2CEE79-1F11-4556-9407-08934327A315
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John E Sims
@ast
John E Sims
@en
John E Sims
@es
John E Sims
@nl
John E Sims
@sl
type
label
John E Sims
@ast
John E Sims
@en
John E Sims
@es
John E Sims
@nl
John E Sims
@sl
prefLabel
John E Sims
@ast
John E Sims
@en
John E Sims
@es
John E Sims
@nl
John E Sims
@sl
P106
P108
P31
P496
0000-0002-5667-9185